LUK HING ENT(08052): Possible delay in the publication of full-year performance for 2025.
Land Qing Entertainment (08052) announced that the publication of the company's annual performance for the year ending December 31, 2025 will be delayed. Recently, a chief accountant and a store manager (who are key personnel responsible for preparing the full-year performance for 2025) have resigned. Their resignations at a crucial time in preparing the full-year performance for 2025 have hindered the progress of providing necessary information and documents to the company's auditors. As a result, the overall progress of the audit work has been affected, and therefore the company needs additional time to prepare the full-year performance for 2025. The expected release date of the full-year performance for 2025 will need to be further discussed and confirmed with the auditors, and will be announced at the appropriate time.
LUK HING ENT (08052) announces that the publication of the company's full-year performance for the year ending December 31, 2025 will be delayed. The company's chief accountant and a store manager (who are key personnel responsible for preparing the 2025 full-year performance) have recently resigned. Their resignation at a critical time in preparing the 2025 full-year performance has hindered the progress of providing necessary information and documents to the company's auditors. As a result, the overall progress of the audit work has been affected, and the company will need additional time to prepare the full-year performance for 2025. The expected publication date of the full-year performance for 2025 will need to be further discussed and determined with the auditors, and will be announced at the appropriate time.
Related Articles
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.

US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.
CF PHARMTECH (02652) expects to achieve a adjusted net profit of approximately 30-35 million yuan in 2025, with stable business operations and continuous progress in innovative research and development.
US Stock Market Move | HSBC Holdings (HSBC.US) fell more than 2% amid reports of plans to cut 20,000 jobs over the next few years.

Service business cooling can't hide strong hardware performance! Morgan Stanley: Apple Inc. (AAPL.US) iPhone production increases significantly, shipments may exceed market expectations.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


